133 related articles for article (PubMed ID: 37335503)
1. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease.
Barbat du Closel L; Bonello-Palot N; Péréon Y; Echaniz-Laguna A; Camdessanche JP; Nadaj-Pakleza A; Chanson JB; Frachet S; Magy L; Cassereau J; Cintas P; Choumert A; Devic P; Leonard Louis S; Gravier Dumonceau R; Delmont E; Salort-Campana E; Bouhour F; Latour P; Stojkovic T; Attarian S
Eur J Neurol; 2023 Oct; 30(10):3265-3276. PubMed ID: 37335503
[TBL] [Abstract][Full Text] [Related]
2. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
[TBL] [Abstract][Full Text] [Related]
3. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
4. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study.
Birouk N; LeGuern E; Maisonobe T; Rouger H; Gouider R; Tardieu S; Gugenheim M; Routon MC; Léger JM; Agid Y; Brice A; Bouche P
Neurology; 1998 Apr; 50(4):1074-82. PubMed ID: 9566397
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1).
Panosyan FB; Laura M; Rossor AM; Pisciotta C; Piscosquito G; Burns J; Li J; Yum SW; Lewis RA; Day J; Horvath R; Herrmann DN; Shy ME; Pareyson D; Reilly MM; Scherer SS;
Neurology; 2017 Aug; 89(9):927-935. PubMed ID: 28768847
[TBL] [Abstract][Full Text] [Related]
6. Genetic and phenotypic profile of 112 patients with X-linked Charcot-Marie-Tooth disease type 1.
Yuan JH; Sakiyama Y; Hashiguchi A; Ando M; Okamoto Y; Yoshimura A; Higuchi Y; Takashima H
Eur J Neurol; 2018 Dec; 25(12):1454-1461. PubMed ID: 29998508
[TBL] [Abstract][Full Text] [Related]
7. Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease.
Dubourg O; Tardieu S; Birouk N; Gouider R; Léger JM; Maisonobe T; Brice A; Bouche P; LeGuern E
Brain; 2001 Oct; 124(Pt 10):1958-67. PubMed ID: 11571214
[TBL] [Abstract][Full Text] [Related]
8. Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease.
Hahn AF; Bolton CF; White CM; Brown WF; Tuuha SE; Tan CC; Ainsworth PJ
Ann N Y Acad Sci; 1999 Sep; 883():366-82. PubMed ID: 10586261
[TBL] [Abstract][Full Text] [Related]
9. [The application of scales and characteristics of disability in the common genotypes of Charcot-Marie-Tooth disease].
Liu X; Zhang RX; Liu L; Xie YZ; Lin ZQ; Zhao Q; Cao WQ; Zhu XY; Li XB
Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(2):131-136. PubMed ID: 33455129
[No Abstract] [Full Text] [Related]
10. A Review of X-linked Charcot-Marie-Tooth Disease.
Wang Y; Yin F
J Child Neurol; 2016 May; 31(6):761-72. PubMed ID: 26385972
[TBL] [Abstract][Full Text] [Related]
11. Clinical characterization and genetic analysis of Korean patients with X-linked Charcot-Marie-Tooth disease type 1.
Hong YB; Park JM; Yu JS; Yoo DH; Nam DE; Park HJ; Lee JS; Hwang SH; Chung KW; Choi BO
J Peripher Nerv Syst; 2017 Sep; 22(3):172-181. PubMed ID: 28448691
[TBL] [Abstract][Full Text] [Related]
12. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families.
Nicholson G; Nash J
Neurology; 1993 Dec; 43(12):2558-64. PubMed ID: 8255457
[TBL] [Abstract][Full Text] [Related]
13. Expansion of the phenotypic spectrum of X-linked Charcot-Marie-Tooth (CMT) disease.
Yang Q; Xiao X; Yuan Z; Jiao B; Liao X; Du J
J Clin Neurosci; 2020 Mar; 73():311-313. PubMed ID: 31987637
[TBL] [Abstract][Full Text] [Related]
14. Consortium fine localization of X-linked Charcot-Marie-Tooth disease (CMTX1): additional support that connexin32 is the defect in CMTX1.
Pericak-Vance MA; Barker DF; Bergoffen JA; Chance P; Cochrane S; Dahl N; Exler MC; Fain PR; Fairweather ND; Fischbeck K
Hum Hered; 1995; 45(3):121-8. PubMed ID: 7615296
[TBL] [Abstract][Full Text] [Related]
15. Nerve conduction velocity in CMT1A: what else can we tell?
Manganelli F; Pisciotta C; Reilly MM; Tozza S; Schenone A; Fabrizi GM; Cavallaro T; Vita G; Padua L; Gemignani F; Laurà M; Hughes RA; Solari A; Pareyson D; Santoro L;
Eur J Neurol; 2016 Oct; 23(10):1566-71. PubMed ID: 27412484
[TBL] [Abstract][Full Text] [Related]
16. Three novel mutations in a group of Chinese patients with X-linked Charcot-Marie-Tooth disease.
Chen B; Niu S; Wang X; Yu X; Tang H; Pan H; Zhang Z
Clin Neurol Neurosurg; 2019 Sep; 184():105430. PubMed ID: 31323543
[TBL] [Abstract][Full Text] [Related]
17. Intermediate Charcot-Marie-Tooth disease.
Liu L; Zhang R
Neurosci Bull; 2014 Dec; 30(6):999-1009. PubMed ID: 25326399
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variants.
Record CJ; Skorupinska M; Laura M; Rossor AM; Pareyson D; Pisciotta C; Feely SME; Lloyd TE; Horvath R; Sadjadi R; Herrmann DN; Li J; Walk D; Yum SW; Lewis RA; Day J; Burns J; Finkel RS; Saporta MA; Ramchandren S; Weiss MD; Acsadi G; Fridman V; Muntoni F; Poh R; Polke JM; Zuchner S; Shy ME; Scherer SS; Reilly MM;
Brain; 2023 Oct; 146(10):4336-4349. PubMed ID: 37284795
[TBL] [Abstract][Full Text] [Related]
20. Six novel connexin32 (GJB1) mutations in X-linked Charcot-Marie-Tooth disease.
Lee MJ; Nelson I; Houlden H; Sweeney MG; Hilton-Jones D; Blake J; Wood NW; Reilly MM
J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):304-6. PubMed ID: 12185164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
